Altamira Therapeutics Ltd
OTC:CYTOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Altamira Therapeutics Ltd
OTC:CYTOF
|
BM |
|
C
|
Catalyst Pharmaceuticals Inc
XBER:CN2
|
US |
|
Huneed Technologies
KRX:005870
|
KR |
|
Mercurity Fintech Holding Inc
NASDAQ:MFH
|
CN |
|
S
|
Saras SpA
XMUN:S7A
|
IT |
Shareholder Yield
Current shareholder yield for CYTOF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CYTOF Price
Altamira Therapeutics Ltd
| Average Annual Return | -77.82% |
| Standard Deviation of Annual Returns | 31.13% |
| Max Drawdown | -100% |
| Market Capitalization | 365.8k USD |
| Shares Outstanding | 5 720 000 |
| Percentage of Shares Shorted | 1.35% |
CYTOF Return Decomposition
Main factors of price return
Stock Splits
CYTOF's latest stock split occurred on Dec 13, 2023
The company executed a 1-for-20 stock split, meaning that for every 20 shares held, investors received 1 new share.
Before the split, CYTOF traded at 0.254 per share. Afterward, the share price was about 4.51.
The adjusted shares began trading on Dec 13, 2023. This was stock split number 4 in CYTOF's history, following the previous one in Oct 25, 2022.
